Upadacitinib Phase 3 Trials Identify Psychological and Functional Benefits of Ambitious Treatment Targets in AD Dermatology Times Source link
Top 5 Articles of the Week: April 12-17 Dermatology Times Source link
FDA Accepts sNDA for Delgocitinib Cream to Treat Pediatric Chronic Hand Eczema Dermatology Times Source link
Delgocitinib Sustains Quality of Life Gains Through 52 Weeks in Chronic Hand Eczema Dermatology Times Source link